AbbVie
ABBV
#27
Rank
HK$2.954 T
Marketcap
HK$1,670
Share price
1.78%
Change (1 day)
4.31%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of December 2025 : HK$41.19 Billion

According to AbbVie's latest financial reports the company has HK$41.19 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$40.90 B-5.16%
2024-12-31HK$43.12 B-56.91%
2023-12-31HK$100.09 B38.81%
2022-12-31HK$72.10 B-5.93%
2021-12-31HK$76.65 B16.61%
2020-12-31HK$65.73 B-78.86%
2019-12-31HK$310.93 B392.57%
2018-12-31HK$63.12 B-17.46%
2017-12-31HK$76.48 B53.55%
2016-12-31HK$49.80 B-23.56%
2015-12-31HK$65.16 B0.32%
2014-12-31HK$64.95 B-15.35%
2013-12-31HK$76.72 B24.11%
2012-12-31HK$61.82 B1118.97%
2011-12-31HK$5.07 B5948.41%
2010-12-31HK$83.85 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
HK$106.54 B 158.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$56.95 B 38.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$71.54 B 73.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$29.90 B-27.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$75.33 B 82.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$83.64 B 103.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$44.81 B 8.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$33.33 B-19.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$11.60 B-71.84%๐Ÿ‡บ๐Ÿ‡ธ USA